Acies Bio Progresses with New Fermentation Facility for European Markets
European biotechnology specialist Acies Bio has announced significant progress in the construction and expansion of its new state-of-the-art fermentation facility. Positioned to serve the broader European market, the site will provide much-needed scale-up capacity for the production of bioplastics, biochemicals, and next-generation biomaterials.
Bridging the Fermentation Bottleneck
As the demand for bio-based polymers continues to surge, a critical bottleneck in the global supply chain remains the lack of accessible mid-to-large-scale precision fermentation infrastructure. Acies Bio’s new facility is specifically designed to address this “valley of death” in biomanufacturing. By offering flexible downstream processing and scalable fermentation volumes, the plant will enable developers of polyhydroxyalkanoates (PHA) and other fermented bio-monomers to transition smoothly from pilot-scale testing to commercial production.
The state-of-the-art bioreactors at the new site are engineered to cultivate diverse microbial strains and utilize a variety of sustainable feedstocks, including second-generation agricultural waste. This technological flexibility is vital for producing custom biopolymers that require highly controlled environmental conditions to achieve specific molecular weights and thermal properties.
Strengthening Regional Supply Chains
Beyond its technical capabilities, the capacity expansion represents a strategic win for the European bioplastics sector. By localizing advanced fermentation infrastructure, Acies Bio aims to reduce the continent’s reliance on imported biomaterials and fossil-based supply chains. This localized production model directly supports regional circular economy initiatives and aligns with the stringent sustainability targets set by European regulators.
Looking Ahead
As the facility advances toward completion, Acies Bio is actively engaging with industry partners to secure capacity reservations. Once fully operational, the plant is expected to serve as a vital scale-up hub, accelerating the time-to-market for novel, biodegradable plastics and reinforcing Europe’s competitive edge in the global biomanufacturing landscape.
Source: Read more